Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the immunogenicity and safety of the Envacgen Enterovirus 71 inactivated vaccine in children aged 6 to under 10 years, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterovirus 71 Infection

Drugs mentioned

• Envacgen (Enterovirus 71 inactivated vaccine)

Snippet

Sponsor: Medigen Vaccine Biologics Corp. | Conditions: Enterovirus 71 Inactivated Vaccine | Phase 3 | Status: RECRUITING